According to the Anxiety and Depression Association of America, anxiety disorders are the most common mental complications in the United States affecting more than 40 million adults in the US or at least 18% of the population every year. Although anxiety disorders are highly treatable, only about 36% of anxiety patients receive treatment.
Several factors can lead to anxiety. Some of these factors include brain chemistry, genetics, personality, and drastic life changes. We are all, therefore, prone to anxiety.
Anxiety affects us differently. Some people might feel unprepared, unsure, or nervous when trying something new or before giving a speech. These feelings may manifest in physical symptoms such as headaches, shortness of breath, or clammy hands.
Anxiety is actually an adaptive response that can help us cope with challenges or day to day threats. These responses can help identify and avert potential threats, encourage us to work harder, etc. However, when we don’t respond well to these triggers, they can become maladaptive leading to clinical anxiety disorders.
- A provision in the 2018 Farm Bill makes hemp, marijuana’s no-buzz cousin, no longer a federally illegal substance.
- It allows farmers and other cultivators to grow the leafy, lanky plant and sell its harvest to processors so they can make hemp-based products ranging from foods, beverages and cosmetics to paper, clothing and building materials.
- Twenty-four states have hemp farming.
- CareerBuilder, Indeed, ZipRecruiter and other mainstream job websites list hemp openings.
It won’t get you high, but lots of people are high on hemp. Thanks to the passage of the 2018 Farm Bill last December, hemp — marijuana’s no-buzz cousin — is no longer a federally illegal controlled substance. A provision in the bill allows farmers and other cultivators to grow the leafy, lanky plant, cannabis sativa L, and sell its harvest to processors, who in turn extract and market raw materials to producers of hemp-based products, everything from foods, beverages and cosmetics to paper, clothing and building materials.
Gov. Greg Abbott signed a new law Monday that clears up which CBD products are legal in Texas and will also allow local farmers to grow hemp as a crop.
The law, which received bipartisan support in the state Legislature, goes into effect immediately.
It will allow Texas to set up a federally approved program for farmers to grow hemp as an industrial crop, including procedures for sampling, inspection and testing. It also expands the kind of hemp products that can be legally purchased in Texas to include any hemp or hemp-derived products containing less than 0.3 percent of THC, or tetrahydrocannabinol, the psychoactive compound found in cannabis plants.
This includes cannabidiol, or CBD, products. While Texans have found oils, tinctures and other CBD goods on store shelves for years, those that contained even trace amounts of THC were technically illegal here. Now, as long as these products are derived from hemp, contain less than 0.3 percent THC and meet other labeling and quality standards, they are legal.
Cannabidiol (CBD) is an exciting focus of medical research, popular media, and legislation related to cannabis. Its presence is becoming ubiquitous on the shelves of health food stores and search engine results for numerous medical conditions, but don’t believe everything you hear. While CBD is an incredibly safe and therapeutic component of cannabis, there are many myths and misconceptions associated with it. Let’s take a look at a few.
Myth #1: CBD is non-psychoactive and medical; THC is recreational.
Both lay and scientific literature have classified CBD as a “non-psychoactive” substance, meaning that it does not alter one’s consciousness. But how could CBD fail to impact consciousness when it’s been shown to have anti-anxiety, anti-psychotic, anti-craving, alerting, and mood-elevating effects in human studies?
CBD clearly impacts our psyche, often in beneficial ways. It does not, however, impair mental or physical function in most consumers, even very high doses. Thus, CBD can be considered psychoactive, but “non-impairing” or “non-intoxicating.”
Angela Post wasn’t supposed to study hemp. The North Carolina State agriculture researcher focuses on small grains like wheat and barley. But after the 2014 Farm Bill allowed states to investigate hemp, it became clear the seeds were lucrative. Post had the right equipment to study them, so the job was hers.
The bill legalizes the crop, allowing any farmer to grow it — whether or not they know how.
At first, Post thought hemp would get as much attention as the other alternative crops she and her colleagues dabble in. “We didn’t know how fast it would grow,” she says. Once the work garnered the attention of hundreds of would-be hemp farmers, “that’s when we got a sense it was something bigger than anticipated.”
Since then, Post’s work has expanded beyond hemp seeds — and her expertise — to fiber and flowers, which contain cannabidiol, or CBD, which is extracted for use in seizure medications and over-the-counter tinctures. But there’s no turning down hemp studies if you’re an agricultural researcher in one of the states where residents might want to grow the crop, including North Carolina, Vermont, and Kentucky.
New Frontier Data estimates the US hemp sales will jump to $2.6 billion. Projections divide the market into CBD sales and food, fiber, fuel.
Estimates suggest CBD values to reach $1.3 billion
The U.S. Drug Enforcement Administration has taken some cannabidiol out of the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval.
It’s a decision that immediately affects CBD producers but also signals the agency’s first admission that the plant has medical value.
The DEA announced Thursday that drugs including CBD with THC content below 0.1% are now considered Schedule 5 drugs, as long as they have been approved by the U.S. Food and Drug Administration.
It is the first time the agency has lowered any type of cannabis from Schedule 1.